المؤلفون: Peter C Wigfield, Bart Heeg, Mario Ouwens

المصدر: Journal of Comparative Effectiveness Research, Vol 13, Iss 1 (2023)

مصطلحات موضوعية: area between curves, markov models, optimization, state transition model, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2042-6313

URL الوصول: https://doaj.org/article/271a40a48d2f467f833d5ed61a5cae3c

المؤلفون: Bart Heeg, Andre Verhoek, Gabriel Tremblay, Ofir Harari, Mohsen Soltanifar, Haitao Chu, Satrajit Roychoudhury, Joseph C Cappelleri

المصدر: Journal of Comparative Effectiveness Research, Vol 12, Iss 3 (2023)

مصطلحات موضوعية: bayesian hierarchical modelling, immunotherapies, indirect treatment comparisons, mixture cure, network meta-analysis, oncology, survival extrapolation, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2042-6313

URL الوصول: https://doaj.org/article/bda791ab4a2a40429f0b41dea9350d65

المؤلفون: Philippe Moreau, Cyrille Hulin, Sonja Zweegman, Mahmoud Hashim, Yannan Hu, Bart Heeg, Carla deBoer, Veronique Vanquickelberghe, Tobias Kampfenkel, Jianming He, Annette Lam, Sarah Cote, Pieter Sonneveld

المصدر: eJHaem, Vol 2, Iss 1, Pp 66-80 (2021)

مصطلحات موضوعية: clinical trials, monoclonal antibodies, multiple myeloma, thalidomide, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2688-6146

URL الوصول: https://doaj.org/article/431d42479384417ebf48d21721253a67

المؤلفون: Lorenzo G. Mantovani, Patrizia Berto, Anna D. Ausilio, Bart Heeg

المصدر: Farmeconomia: Health Economics and Therapeutic Pathways, Vol 5, Iss 1, Pp 5-11 (2004)

مصطلحات موضوعية: Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://journals.seedmedicalpublishers.com/index.php/FE/article/view/782; https://doaj.org/toc/2240-256X

URL الوصول: https://doaj.org/article/612b0f9b25874e4e871317a115a3fd6e

المؤلفون: Andre Verhoek, Parneet Cheema, Barbara Melosky, Benoit Samson, Frances A. Shepherd, Filippo de Marinis, Thomas John, Yi-Long Wu, Bart Heeg, Nadia Van Dalfsen, Benjamin Bracke, Miguel Miranda, Simon Shaw, Daniel Moldaver

المصدر: PharmacoEconomics - Open. 7:455-467

مصطلحات موضوعية: Pharmacology, Health Policy, Pharmacology (medical)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b03bfb225b750f2d67dad202bdaac773
https://doi.org/10.1007/s41669-023-00396-0

المؤلفون: Jianming He, Heather Berringer, Bart Heeg, Haoyao Ruan, Tobias Kampfenkel, Harikumaran R. Dwarakanathan, Stephen Johnston, João Mendes, Annette Lam, Sacheeta Bathija, Eric Mackay

المصدر: Advances in Therapy. 39:4230-4249

مصطلحات موضوعية: Bortezomib, Clinical Trials, Phase I as Topic, Clinical Trials, Phase III as Topic, Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humans, Standard of Care, Pharmacology (medical), General Medicine, Neoplasm Recurrence, Local, Multiple Myeloma, Dexamethasone, Thalidomide

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7c40b38ff296c699630595fed8acc2
https://doi.org/10.1007/s12325-022-02226-x

المؤلفون: T Alexander Russell-Smith, Laura Gurskyte, Bogdan Muresan, Carla M Mamolo, Ana Gezin, Joseph C Cappelleri, Bart Heeg

المصدر: Future Oncology. 18:2029-2039

مصطلحات موضوعية: Leukemia, Myeloid, Acute, Cancer Research, Oncology, Cytarabine, Humans, General Medicine, Gemtuzumab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac099498d9f4a75609c2c6a23a9d841
https://doi.org/10.2217/fon-2021-1355

المؤلفون: Bart Heeg, Andrea Garcia, Sophie van Beekhuizen, Andre Verhoek, Ilse van Oostrum, Satrajit Roychoudhury, Joseph Christopher Cappelleri, Maarten Jacobus Postma, Mario Johannes Nicolaas Martinus Ouwens

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Value, Affordability and Sustainability (VALUE), Microbes in Health and Disease (MHD)

المصدر: Journal of Comparative Effectiveness Research, 11(15), 1121-1133. FUTURE MEDICINE LTD

مصطلحات موضوعية: DOCETAXEL, piecewise, MIXTURE, Health Policy, MODELS, MULTICENTER, decision framework, fractional polynomials, immunotherapies, OPEN-LABEL, indirect comparisons, CANCER, ATEZOLIZUMAB, oncology, survival extrapolation, splines, CROSS-VALIDATION, time-to-event end point, mixture modeling, network meta-analysis, parametric modeling

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84333b4e0163d9b38f370767f0d3d032
https://doi.org/10.2217/cer-2022-0044

المؤلفون: Bart Heeg, Ilse van Oostrum, Erik Buskens, Gianluca Baio, Maarten J. Postma, Antonio Remiro-Azócar, Mario Ouwens

المساهمون: Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Microbes in Health and Disease (MHD)

المصدر: Value in Health, 24(9), 1294-1301. ELSEVIER SCIENCE INC

مصطلحات موضوعية: Male, PREDNISONE, Technology Assessment, Biomedical, Cost effectiveness, Cost-Benefit Analysis, Population, Antineoplastic Agents, Medical Oncology, ECONOMIC-EVALUATION, Cross-validation, COST-EFFECTIVENESS, 03 medical and health sciences, 0302 clinical medicine, Statistics, Credible interval, Humans, LIFE EXPECTANCY, EVALUATE, 030212 general & internal medicine, Mortality, CROSS-VALIDATION, education, parametric modeling, Mathematics, Face validity, Parametric statistics, Aged, Aged, 80 and over, education.field_of_study, Likelihood Functions, general population mortality, 030503 health policy & services, Health Policy, additive hazards, Public Health, Environmental and Occupational Health, incremental life-years, Middle Aged, Survival Analysis, CANCER, RHEUMATOID-ARTHRITIS, Economic evaluation, Parametric model, MELPHALAN, Female, 0305 other medical science, FOLLOW-UP

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6abc4fde2cddc1ab4a55cf3ebebab12d
https://research.rug.nl/en/publications/2708ad11-cdaf-425d-969f-66f91876a9ea

المؤلفون: Maarten J. Postma, Bart Heeg, Joseph C. Cappelleri, B. Muresan, Carla Mamolo

المساهمون: Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Microbes in Health and Disease (MHD)

المصدر: Applied Health Economics and Health Policy, 19(6), 929-940. Springer International Publishing AG
Applied Health Economics and Health Policy

مصطلحات موضوعية: Adult, Oncology, Economics and Econometrics, medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, NILOTINIB, ECONOMIC-EVALUATION, IMATINIB, Second line, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, Nitriles, Humans, TOOL, Medicine, Original Research Article, Protein Kinase Inhibitors, health care economics and organizations, DASATINIB, Aniline Compounds, Adult patients, business.industry, Health Policy, Imatinib, General Medicine, Chronic phase chronic myeloid leukemia, Dasatinib, THRESHOLDS, Nilotinib, Imatinib Mesylate, Quinolines, Quality-Adjusted Life Years, ADJUSTED INDIRECT COMPARISONS, business, Bosutinib, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f0e62dd4c3be6329b04724f07edb2d
https://doi.org/10.1007/s40258-021-00666-0